Filing Details
- Accession Number:
- 0000908662-15-000097
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-26 16:29:09
- Reporting Period:
- 2015-02-26
- Filing Date:
- 2015-02-26
- Accepted Time:
- 2015-02-26 16:29:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 907562 | Dyax Corp | DYAX | Services-Commercial Physical & Biological Research (8731) | 043053198 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1573163 | D. Andrew Ashe | C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756 | General Counsel & Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-02-26 | 1,500 | $15.34 | 36,527 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan. The sales were primarily intended to provide liquidity sufficient to cover tax obligations due in connection with the vesting of restricted stock.
- Includes 1,750 shares acquired under Dyax Corp.'s 1998 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c).
Billionaire Hedge Funds
